RecallDepth
Class II Terminated

Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Subcutaneous Use. Single-Dose Prefilled Syringe. Product of France, Manufactured by: Genentech, Inc. A Member of the Roche Group, South San Francisco, CA 9480-4990. NDC: 50242-215-01

Company
Genentech, Inc.
Recall Initiated
June 9, 2021
Posted
July 14, 2021
Recall Number
D-0650-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
88,620 prefilled syringes
Firm Location
South San Francisco, CA, United States

Reason for Recall

Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content were detected at the 12 month testing time point.

Distribution

Product was distributed nationwide

Lot / Code Info

Lot No.: 3352758, Exp. Date Aug 2021; Lot No.: 3352759, Exp. Date Aug 2021

More recalls by Genentech, Inc.

View all recalls by this company →

Other recent Class II Drug recalls